title: Response to: Treatment prolongation or quadruple therapy:- Individualization by geographical region.
authors.affiliation: Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
authors.forename: Fahad
authors.initials: F
authors.lastname: Alsohaibani
authors.forename: Hamad
authors.initials: H
authors.lastname: Al Ashgar
authors.forename: Khalid
authors.initials: K
authors.lastname: Al Kahtani
authors.forename: Musthafa
authors.initials: M
authors.lastname: Peedikayil
authors.forename: Abdulrahman
authors.initials: A
authors.lastname: Alfadda
authors.forename: Mohammed Q
authors.initials: MQ
authors.lastname: Khan
authors.forename: Ingvar
authors.initials: I
authors.lastname: Kageri
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*
chemical_list: D000890:Anti-Infective Agents; D054328:Proton Pump Inhibitors
references.citation: Saudi J Gastroenterol. 2016 Jan-Feb;22(1):77-8
references.pmid: 26831611
references.citation: Gut. 2012 May;61(5):646-64
references.pmid: 22491499
references.citation: World J Gastroenterol. 2014 Dec 21;20(47):18013-21
references.pmid: 25548501
references.citation: Medicine (Baltimore). 2015 May;94(17):e685
references.pmid: 25929897
references.citation: Saudi J Gastroenterol. 2015 Jul-Aug;21(4):220-5
references.pmid: 26228365